Tumor regression after systemic administration of transferrin-targeted TNFalpha plasmid-dendrimer conjugates.
Park
Kinam
K
Purdue University, Departments of Biomedical Engineering and Pharmaceutics, West Lafayette, Indiana, USA. kpark@purdue.edu
D000818:Animals; D050091:Dendrimers / Q000737:chemistry*; D015870:Gene Expression; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D009369:Neoplasms / Q000628:therapy*; D010957:Plasmids / Q000008:administration & dosage*; D014168:Transferrin / Q000737:chemistry*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D050091:Dendrimers; D014168:Transferrin; D014409:Tumor Necrosis Factor-alpha